FIELD: medicine, phthisiobacteriology. SUBSTANCE: invention proposes the developed nutrient medium for mycobacterium tuberculosis used for assay of their medicinal resistance based on the modified synthetic Soton's medium that comprises additionally 0.35% of nutrient agar and 25% of equine serum. Using this medium provides obtaining the visual growth of mycobacterium tuberculosis by 2.1-2.8-fold more rapidly (on 3-5 days) as compared on the known medium. The proposed medium can be used in practice of phthisiobacteriological laboratories for the accelerated obtaining data about the medicinal resistance of clinical strains to isoniazid, streptomycin and rifampicin. EFFECT: improved assay method, valuable properties of medium. 2 tbl
Title | Year | Author | Number |
---|---|---|---|
CULTURE MEDIUM FOR DETERMINING DRUG SUSCEPTIBILITY OF M tuberculosis TO MAIN ANTI-TUBERCULOSIS DRUGS | 2010 |
|
RU2470071C2 |
BROTH FOR ACCELERATED DETERMINATION OF TUBERCULOSIS MYCOBACTERIUM DRUG RESISTANCE | 2003 |
|
RU2252260C2 |
METHOD FOR DIAGNOSIS OF SENSITIVITY OF MYCOBACTERIUM TUBERCULOSIS TO ANTITUBERCULOSIS PREPARATIONS | 2005 |
|
RU2315113C2 |
KIT FOR EXAMINATION OF DRUG SENSITIVITY AND PRIMARY IDENTIFICATION OF TUBERCULOSIS MYCOBACTERIA | 2003 |
|
RU2268298C2 |
MEANS, POSSESSING ANTI-TUBERCULOSIS ACTION | 2014 |
|
RU2549477C1 |
METHOD OF TREATING PULMONARY TUBERCULOSIS FEATURING PREDOMINANTLY EXUDATIVE TYPE OF INFLAMMATION | 1990 |
|
RU2008902C1 |
NUTRIENT MEDIUM FOR CULTURING MYCOBACTERIUM AND NOCARDIOFORMOUS ACTINOMYCES | 2006 |
|
RU2322495C2 |
METHOD OF DETERMINING DRUG SUSCEPTIBILITY OF TUBERCULOSIS MYCOBACTERIA | 2003 |
|
RU2255977C1 |
PHARMACOLOGICAL COMPOSITION WITH ANTI-TUBERCULOSIS ACTION | 2008 |
|
RU2412715C2 |
COMBINED ANTITUBERCULOUS COMPOSITION | 2009 |
|
RU2413517C1 |
Authors
Dates
2004-04-10—Published
2001-07-30—Filed